Parkemed en es it fr

Parkemed Brand names, Parkemed Analogs

Parkemed Brand Names Mixture

  • No information avaliable

Parkemed Chemical_Formula


Parkemed RX_link

Parkemed fda sheet

Parkemed msds (material safety sheet)

Parkemed MSDS

Parkemed Synthesis Reference

No information avaliable

Parkemed Molecular Weight

241.285 g/mol

Parkemed Melting Point

230-231 oC

Parkemed H2O Solubility

20 mg/L

Parkemed State


Parkemed LogP


Parkemed Dosage Forms

Bolus; Capsule; Capsule (enteric-coated); Drops; Liquid; Lotion; Powder; Powder for solution; Shampoo; Soap bar; Solution; Stick; Syrup; Tablet; Tablet (extended-release)

Parkemed Indication

For the treatment of rheumatoid arthritis, osteoarthritis, dysmenorrhea, and mild to moderate pain, inflammation, and fever.

Parkemed Pharmacology

Mefenamic acid, an anthranilic acid derivative, is a member of the fenamate group of nonsteroidal anti-inflammatory drugs (NSAIDs). It exhibits anti-inflammatory, analgesic, and antipyretic activities. Similar to other NSAIDs, mefenamic acid inhibits prostaglandin synthetase.

Parkemed Absorption

Mefenamic acid is rapidly absorbed after oral administration.

Parkemed side effects and Toxicity

Oral, rat LD50: 740 mg/kg. Symptoms of overdose may include severe stomach pain, coffee ground-like vomit, dark stool, ringing in the ears, change in amount of urine, unusually fast or slow heartbeat, muscle weakness, slow or shallow breathing, confusion, severe headache or loss of consciousness.

Parkemed Patient Information

Parkemed Organisms Affected

Humans and other mammals